MENINGITIS
Meningitis is an inflammatory process of the meninges and CSF
Demography of Meningococcal Meningitis
♦ Meningitis belt ♦ epidemic zones cases
♦ sporadic
Causes/Major Pathogens Type Bacterial Viral infection TB meningitis Protozoal Infection Fungal infection
Pathogen (most Common) Strep pneumoniae, E-coli, Neisseria meningitis Coxsackie Virus, Echovirus, Enterovirus, Arbovirus, HIV, HSV-2 M. Tuberculosis Toxoplasma Gondii (toxoplasmosis) Cryptococcus neoformans (cryptococcal meningitis)
Other:
Progressive multifocal leukoencephalopathy (PML) Primary CNS lymphoma, HIVassociated dementia (HAD), Painful sensory and motor peripheral neuropathies, Neurosyphilis
PATHO PHYSIOLOGY Direct to CSF
Microorganisms Via Blood Subarachnoid
Immune Response Space from Astrocytes+Micro glia, Cytokin Release
Inc. BBB permeabilty Fluid leakage from vessels Vasogenic edema
Inc. no. of WBC in CSF Inflammation of Meninges Interstitial edema (Inc. ECF)
Vasculitis of cerebral vessels Dec. cerebral blood flow Ischemia, cytotoxic edema
Cerebral Edema Dec. Cerebral blood flow, Ischemia, apoptosis (Brain Death)
MAJOR FORMS OF MENINGITIS Bacterial
Viral
More serious, less common Immunization available
Less serious, more common No immunization
for some
available
Treatable with antibiotics
Treatment includes waiting it out
More common in winter
More common in summer/ early fall
Classification • • • •
Acute pyogenic (bacterial) meningitis Acute aseptic (viral) meningitis Chronic bacterial infection (tuberculosis). Acute focal suppurative infection (brain abscess, subdural and extradural empyema)
1) Acute Pyogenic Bacterial Meningitis
2) Acute Aseptic (Viral ) Meningitis • Can follow any viral infection • Less danger • Viral meningitis is usually self-limiting and treated • Fever ± delirium, lethargy, disorientation, symptomatically. malaise, headache most common • Stiff neck, photophobia, cranial nerve deficits less common • No focal neurological deficits • Gastrointestinal symptoms: diarrhea, colitis, esophageal ulceration appear in 12-15% of
3) Chronic bacterial infection (tuberculosis/ TB Meningitis)
Complications • Antibiotic treatment------ full recovery • Delayed or untreated cases--- can be fatal • Healing by fibrosis cause obliteration of subarachenoid space--- HYDROCEPHALUS • Brain abscess • Septic shock and skin rashes, why ?
1) Brain abscess
• Causes : 1. complication of bacterial meningitis 2. bacterial endocarditis 3. pulmonary sepsis : pneumonia……etc 4. other sepsis
Brain abscess cause a space occupying lesion in the brain
2) Skin rashes Is due to small skin bleed
• • All parts of the body are affected • The rashes do not fade under pressure • Pathogenesis: a. Septicemia b. wide spread endothelial damage c. activation of coagulation d. thrombosis and platelets aggregation e. reduction of platelets (consumption ) f. BLEEDING 1.skin rashes 2.adrenal hemorrhage Adrenal hemorrhage is called WaterhouseFriderichsen Syndrome. It cause acute adrenal insufficiency and is usually fatal
Work up for Meningitis Physical Exam • Brudzinski’s & Kernig’s sign • Nuchal rigidity • Papilledema Lumbar puncture to obtain CSF Chemistry (glucose & protein) Cytology (WBC# & %PMN’s) Gram stain or rapid identification test (< 24hrs) • CIE (Counterimmunoelectrophoresis), coagglutination, or latex • •
•
agglutination Limulus lysate for gram negative endotoxin PCR (N.meningitidis, S. pneumoniae, H. influenzae, S. agalactiae, L. monocytogenes & enteroviruses) Lactate (>4.2 mmol/L considered positive for bacterial meningitis) Procalcitonin (> 5 micrograms/L suggestive of bacterial meningitis) C-reactive proteins (CRP) (Elevated in bacterial meningitis)
• • • Culture for pathogens (> 24hrs)
Blood, Urine, & Sputum Cultures
Kernig's sign The thigh is flexed on the abdomen, with the knee flexed; attempts to passively extend the knee elicit pain when meningeal irritation is present. Brudzinski's sign: passive flexion of the neck results in spontaneous flexion of the hips and knees. Nuchal rigidity: Inability to flex the neck forward passively due to increased neck muscle tone. It occurs in 70% of adult cases of bacterial meningitis
Jolt accentuation maneuver:
•The patient is told to rapidly rotate his or her head horizontally; if this does not make the headache worse, meningitis is unlikely. •It helps determine whether meningitis is present in patients reporting fever and headache. Kernig’s and Brudzinski’s signs have high specificity but low sensitivity(44%) for the diagnosis of meningitis. Jolt accentuation of headache was determined to have a 97% sensitivity and 60% specificity. It has been suggested that absence of the jolt sign essentially excludes meningitis.
CSF Detail Report Changes in CSF Appearance WBC
Normal
Viral
Crystal-clear
Clear/Turbid
< 5 mm3
25-500 mm3
Pyogenic (Bacterial) Turbid/purule nt > 1000 mm3
< 5 mm3
10-100 mm3
<50 mm3
Mononuclear cells Polymorph cells Protein
Nil
Nil
0.2- 0.4 g/L
0.4-0.8 g/L
200-300/ mm3 0.5-2.0 g/L
Glucose
40-80 mg/dl
30-70 mg/dl
<40 mg/dl
Harrison's Principles of Internal Medicine, 17`Edition, 2008
Tuberculosis Turbid/visco us < 500 mm3 100-300 mm3 0-200/ mm3 1-5g/L 20-40 mg/dl
Empirical Therapy For ABM Age
Common Pathogen
Anti microbial
<1 month
Streptococcus agalactiae, Escherichia coli, Listeria monocytogenes, Klebsiella species
Ampicillin plus cefotaxime or ampicillin plus an aminoglycoside Vancomycin plus a
1-23 month
Streptococcus pneumoniae, Neisseria meningitidis, S. agalactiae, Haemophilus influenzae, E. coli
2-50 yrs
N. meningitidis, S. pneumoniae
Vancomycin plus a third-generation cephalosporina,b
> 50 yrs
S. pneumoniae, N. meningitidis, L. monocytogenes, aerobic gram-negative bacilli
Vancomycin plus ampicillin plus a third-generation cephalosporina,b
third-generation cephalosporina,b
ftriaxone or cefotaxime me experts would add rifampin if dexamethasone is also given. •Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004 Nov 1;39(9):1267-84. [120 references] Pub Med
Recommendations for Appropriate use of Antimicrobials at Hospitals in Pakistan Departments of Infectious Disease and Infection Control
Total Daily Dose and Dosing Interval Antimicrobia Child (>1 month) l Agent
Adult
Ampicillin 200 (mg/kg)/d, 12 g/d, q4h q4h Cefotaxime 200 (mg/kg)/d, 12 g/d, q4h q6h Ceftriaxone 100 (mg/kg)/d, 4 g/d, q12h q12h Ceftazidime 150 (mg/kg)/d, 6 g/d, q8h q8h Gentamicin 7.5 (mg/kg)/d, 7.5 (mg/kg)/d, q8h b q8h Metronidazo 30 (mg/kg)/d, q6h 1500–2000 mg/d, le q6h Penicillin G 400,000 (U/kg)/d, 20–24 million U/d, q4h q4h Vancomycin 60 (mg/kg)/d, q6h 2 g/d, q12hb All antibiotics are administered intravenously; doses indicated assume normal renal and hepatic function. Doses should be adjusted based on serum peak and trough levels: gentamicin therapeutic level: peak: 5–8 g/mL; trough: <2 g/mL; vancomycin therapeutic level: peak: 25–40 g/mL; trough: 5–15 g/mL. a b
Harrison's Principles of Internal Medicine,
Duration OF Therapy For ABM Microorganism
Duration of therapy, days
Neisseria meningitidis
7
Haemophilus influenzae
7
Streptococcus pneumoniae
10-14
Streptococcus agalactiae
14-21
Aerobic gram-negative bacillia Listeria monocytogenes
21 >21
Duration of Antimicrobial Therapy for Bacterial Meningitis Based on Isolated Pathogen (A-III) a Duration in the neonate is 2 weeks beyond the first sterile CSF culture or >3 weeks, whichever is longer. •Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004 Nov 1;39(9):1267-84. [120 references] PubMed
Adjunct Steroid Therapy for Infants, Children and Adults • Dexamethasone should be initiated 10-20 min prior to, or at least concomitant with, the first antimicrobial dose, at 0.15 mg/kg every 6 h for 2-4 days. • Adjunctive dexamethasone should not be given to the patients who have already received antimicrobial therapy, because administration of dexamethasone in this circumstance is unlikely to improve patient outcome At present, there are insufficient data to make a recommendation on the use of adjunctive dexamethasone in neonates with bacterial meningitis •Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004 Nov 1;39(9):1267-84. [120 references] Pub Med
Management and Treatment Of TBM Daily administration of Rifampicin 600 mg (450 mg for weight <55 KG) Isoniazid 300 mg Pyrizinamide 1.5 g for <55 Kg & 2 gm for above 55 Kg. (Initial 2 Months) All in combination 30 min before breakfast. Treatment require For PTB is six months For bone TB is nine months & For TB meningitis is 1 year. The addition of a fourth drug STREPTOMYCIN is left to the choice of the local physicians and their experience, with little evidence to support the use of one over the other Tarakad S Ramachandran, MBBS, FRCP(C), FACP, Chief, Department of Neurology, Crouse Irving Memorial Hospital; Professor, Department of Neurology, State University of New York Upstate Medical University Contributor Information and Disclosures Updated: Mar 9, 2007 from E medicine web Md
Vaccines For Meningitis Routine immunization can go a long way toward preventing meningitis. The vaccines against Hib, measles, mumps, polio, meningococcus, and pneumococcus can protect against meningitis caused by these microorganisms. Bacteria H. influenzae S. Pneumoniae N. Meningitidis
Polysaccharide Conjugate Vaccine Vaccine PRP PRP-OMP (PedvaxHIB, Comvax) PPV23 PCV7 (Prevnar) Quadrivalent Quadrivalent A/C/Y/W135 A/C/Y/W135 (Menactra) (Menomune) Monovalent C (Meningitec) WHO Fact sheet N°141 Revised May 2003
[email protected] [email protected]